SLC44A1 and pancreatic adenocarcinoma: Withaferin A affects the expression of 4 different genes (CD47, CENPB, PAQR4, SLC44A1) that, in turn, affect the survival plots in patients with uterine corpus endometrial carcinoma (CD47), brain lower-grade glioma (CENPB), kidney renal clear cell carcinoma (PAQR4), kidney renal papillary cell carcinoma (PAQR4), liver hepatocellular carcinoma (PAQR4) and pancreatic adenocarcinoma (SLC44A1) (Table 1).